National Scleroderma Foundation
Homepage | Forward to a Friend | Make a Donation

National Scleroderma Foundation Logo 2022 eletter

 

eLetter #977 | July 8, 2022  

National Scleroderma Conference 2022.jpg

There is Still Time to Register for the National Scleroderma Conference 

Join us on July 15, 16, and 17 at our virtual National Scleroderma Conference! 

Connecting Our Journey will provide informational sessions on topics such as: 

  • Life with scleroderma 
  • Building your scleroderma network 
  • Connecting with resources and support systems 
  • Current and upcoming scleroderma research 
  • And, so much more! 

The conference will take place July 15-17 and will feature 30+ scleroderma-focused sessions presented by experts from across the country, and some sessions will be live, giving you the opportunity to talk directly to our presenters!

REGISTER

Thank you to our Patron Sponsors!

Horizon Therapeutics logo - 300pxBoehringer IngelheimJanssen


Chronic Disease Day 2022

Chronic Disease Day

July 10 is Chronic Disease Day. As a chronic disease, scleroderma persists and can affect someone throughout all stages of life. On #ChronicDiseaseDay, the National Scleroderma Foundation would like to recognize the strength and perseverance of the 150+ million people affected by a chronic disease, especially those affected by scleroderma.


World Scleroderma Day 2022 YouTube Cover

World Scleroderma Day Video Available 

Thank you to everyone who has advocated for Scleroderma Awareness Month by sharing our content on social media. In particular, World Scleroderma Day was commemorated by a special video emphasizing the experiences of individuals affected by scleroderma. You can watch it now on our YouTube channel.

Keep the momentum going by sharing our content on Facebook, Twitter, LinkedIn, and Instagram.

WATCH


Become a Member Today

Become a Member 

For only $25 a year ($35 USD for those living outside of the USA), you can support our mission and gain special access to our quarterly magazine, the Voice, along with a discounted registration fee to our annual National Scleroderma Conference.

Become a member yourself or give the gift of membership to a friend or family member by completing our online membership form or calling us toll-free at (800) 722-HOPE [4673].

MEMBERSHIP

 


SPIN

SPIN Newly Diagnosed and Caregivers Virtual Support Groups

Are you living with scleroderma and identify as transgender, non-binary, Two-Spirit, or another non-cisgender identity? SPIN is looking for individuals to join an advisory team to provide input on projects related to the impact of sex/gender on scleroderma. If you are interested or would like more information, please contact spingeneral@gmail.com

 


Pride Month Flag Image.png

LGBTQ+ Virtual Support Group

The National Scleroderma Foundation stands with LGBTQ+ members of our community across the country. If you are interested in starting/joining an LGBTQ+ scleroderma support group, please let us know!

 


National Scleroderma Foundation new logo 2022

Newly Diagnosed and Caregivers Virtual Support Groups

The National Scleroderma Foundation would like to invite members of our community who are interested in starting/joining a Newly Diagnosed or Caregivers virtual support group to please let us know! We will be creating a focus group for each support group to help determine best dates and times to meet, gauge participation, and find leaders and co-leaders for the support groups.

 


National Scleroderma Foundation new logo 2022

The 20%: A Virtual Support Group for Males Living with Scleroderma 

VIRTUAL: July 27, 2022; 7- 8 p.m. 

Scleroderma diagnoses are less common amongst men. In fact, only 20% of individuals living with scleroderma are made up of males. We have designed a support group especially for males with scleroderma. In it, you will learn scleroderma tips and resources and find support from others in your position. Each meeting, we will focus on a different topic from mental health to intimacy and so much more. The group meets on the fourth Wednesday of the month (with some exceptions) from 7 to 8 p.m.

 REGISTER

RENEW

RENEW Study Looking for Participants  

RENEW, a fatigue management intervention program at the University of Michigan, is looking for participants for an intervention study targeting problematic scleroderma symptoms. The study is open to all participants with a special interest in members of the BIPOC community.  During the study, individuals will be randomized into two groups. One group will receive the 12-week program with resources for symptom self-management right away, and the other group will be given access to the program after 12 weeks. The study will compensate individuals for their time.

To be eligible you must be:

  • 18 years or older having fatigue that impacts your daily life and functioning 
  • Diagnosed with systemic sclerosis (scleroderma) 
  • Access to a computer and an internet connection 
  • Ability to speak and read English

For more information, please contact us at 734-615-8543 or sbolde@med.umich.edu. If you are interested in participating, go to the RENEW website.

 

Grant Opportunities Image

Now Accepting Scleroderma Research Grant Applications 

If you hold a faculty-equivalent position and are newly pursuing a career in scleroderma-related research, apply to our New Investigators Grant. Anyone who is an established researcher both inside and outside the field of scleroderma research who wishes to propose pilot studies to obtain preliminary data dealing with a highly innovative and/or highly relevant theme related to scleroderma should apply for our Established Investigator Grants.

To learn more about our research grants or apply, visit our website. We will accept applications until September 15, 2022.

Advertisement
June United Ad
Decode Ad 2022
 
 
QUICK LINKS
Advocacy
Contact Us
Become a Member
What is Scleroderma
Calendar of Events
Online Chat
Make a Gift
Home
 
SOCIAL MEDIA
Facebook Twitter Instagram YouTube linkedin-icon
 
SPONSORS
 

Gold 
Janssen

 

Silver 

Boehringer Ingelheim

Horizon Therapeutics logo - 300px

 

 

Disclaimer: The National Scleroderma Foundation in no way endorses any drugs, treatments, clinical trials, or studies reported in the eLetter. Information is provided to keep the readers informed. Because the manifestations and severity of scleroderma vary among individuals, personalized medical management is essential. Therefore, it is strongly recommended that all drugs and treatments be discussed with the reader’s physician(s) for proper evaluation and treatment.

Powered by Blackbaud  Unsubscribe | Visit our web site | Contact Us | Donate
300 Rosewood Drive, Suite 105, Danvers, MA 01923 tel: 800-722-HOPE (4673)
© 2024 All rights reserved.